APAC Membrane Chromatography Market

APAC Membrane Chromatography Market Size (2022 to 2027)

The membrane chromatography market in APAC is predicted to expand at a CAGR of 19.63% and be worth USD 90.31 million by 2027.

Membrane chromatography is a well-known bioprocessing technology frequently employed to capture big particles like viruses and viral vectors and polish processes to remove DNA, host cell protein impurities (HCP), and viruses. The growing demand for biopharmaceuticals and increased regulatory scrutiny of the cleaning validation of downstream purification processes are driving this market forward.

Ion-exchange chromatography (IC) is a type of chromatography in which ions and polar molecules are separated depending on their affinity for an ion exchanger. It operates on large proteins, tiny nucleotides, amino acids, and other charged molecules.

There has been an increasing interest in using IC to analyze pharmaceutical medications in the Asia Pacific area. In product development and quality control testing, IC is employed in various ways. For example, IC is used to increase the stability and solubility features of pharmaceutically active drug molecules and identify systems that have a better tolerance for organic solvents. It is also commonly used to detect and quantify excipients or inactive substances used in pharmaceutical formulations.

The advantages associated with ion exchange membrane chromatography, such as scalability, robustness, disposable nature, high throughput, rapid processing, reduced buffer consumption, and a validation-free environment, have been attributed to its wide applications in antibody polishing and virus purification.

The fundamental downside of these approaches is that they concentrate proteins rather than purifying them, which is essential in many applications. Therefore, it is only feasible to focus and purify the finished product using chromatography techniques based on particular affinity.

This market is projected to be constrained by the limited application of membrane chromatography in large-scale manufacturing. During the forecast period, the membrane chromatography market is likely to be constrained by a shortage of skilled specialists and technological constraints associated with the technology. Alternative ways are also having a detrimental impact on the market. These factors are expected to restrain the APAC Membrane Chromatography market during the forecast period.

This research report on the APAC membrane chromatography market has been segmented and sub-segmented into the following categories:

By Product:

• Affinity Membrane Chromatography
• Hydrophobic Interaction Membrane Chromatography (HIMC)
• Ion Exchange Membrane Chromatography

By Application:

• Chemical
• Sewage Treatment

By End-User:

• Pharmaceutical and Biopharmaceutical Companies
• CROs
• Academic and Research Institutes

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Most membrane chromatography techniques and processed instruments are manufactured in the Asia Pacific by worldwide leading companies. Industry leaders have built their position in the market by investing more in research and having a better distribution system. Furthermore, some small players are emerging throughout Asia-Pacific due to increased awareness. This has also aided the market's expansion. The Asia Pacific Membrane Chromatography market is expected to increase due to rising demand for pharmaceuticals and the government's substantial investments in biopharmaceutical R&D. The market is likely to develop due to the rising acceptance of new technological advancements in the pharmaceutical sector and the availability of infrastructure.

In this cluster of regional markets, China will continue to be fastest expanding. The Asia-Pacific market is expected to reach $74.3 million by 2027, led by Australia, India, and South Korea. In addition, the widespread use of ion exchange membrane chromatography in virus purification and anti-body polishing applications has created attractive market prospects.

Australia is the second-largest market for APAC Membrane Chromatography, after China. It encourages pharmaceutical research and development, resulting in very high healthcare spending. Many enterprises from around the world are encouraged to operate in this region due to these rules.

KEY MARKET PLAYERS:

Sartorius AG, Danaher Corporation, Merck Millipore, Thermo Fisher Scientific, 3M Company, GE Healthcare, Asahi Kasei Corporation, Cole-Parmer Instrument Company, LLC, GL Sciences Inc., Regis Technologies, Inc. and Restek Corporation are some of the leading companies in the European membrane chromatography market.